NRGEX | STSIX | NRGEX / STSIX | |
Total Expense Ratio | 0.03 | 1.00 | 3% |
Annual Report Gross Expense Ratio | 0.69 | 1.09 | 63% |
Fund Existence | 4 years | 19 years | - |
Gain YTD | -3.342 | 12.810 | -26% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.71B | 452M | 1,928% |
Annual Yield % from dividends | 0.54 | 0.00 | - |
Returns for 1 year | -9.46 | 5.52 | -171% |
Returns for 3 years | 8.17 | 28.69 | 28% |
Returns for 5 years | N/A | -8.09 | - |
Returns for 10 years | N/A | 5.06 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIB | 67.02 | 0.80 | +1.21% |
ProShares Ultra Nasdaq Biotechnology | |||
PCY | 21.79 | 0.04 | +0.18% |
Invesco Emerging Markets Sov Debt ETF | |||
XXCH | 32.39 | N/A | N/A |
Direxion Daily MSCI Em Mkt Ex Chn Bl 2X | |||
DAX | 44.49 | -0.31 | -0.69% |
Global X DAX Germany ETF | |||
ARMH | 71.38 | -2.26 | -3.07% |
ARM HOLDINGS PLC ADRHEDGED ARMH |